Glukoza Braun

Glukoza Braun is a sterile intravenous solution that contains glucose monohydrate as the active ingredient. It is supplied as a parenteral carbohydrate solution intended for use in the European market. The product provides an immediate source of glucose for patients requiring energy support, fluid replacement, or correction of low blood sugar. It is available by prescription and administered by healthcare professionals in clinical settings under supervision.

Glukoza Braun is indicated for several clinical situations where rapid glucose delivery is required.

- Treatment of hypoglycemia when oral glucose is not feasible. - Component of parenteral nutrition regimens for patients unable to receive enteral feeding. - Fluid and electrolyte replacement in conjunction with other intravenous solutions. - Energy source during perioperative care or critical illness. - Support for patients with metabolic disorders that limit endogenous glucose production.

Adverse reactions to Glukoza Braun are generally related to the intravenous administration of a carbohydrate solution and may vary in frequency.

Common: - Hyperglycemia due to excess glucose load. - Local irritation or pain at the injection site. - Nausea or vomiting. - Headache.

Serious: - Severe hyperglycemia with osmotic diuresis. - Allergic or anaphylactic reactions such as rash, itching, or respiratory distress. - Electrolyte imbalance, particularly hyponatremia, when administered in large volumes. - Phlebitis or thrombophlebitis at the infusion site.

When prescribing Glukoza Braun, clinicians should evaluate patient-specific factors and monitor relevant parameters to reduce the risk of complications.

- Assess blood glucose levels before and during infusion to avoid hyperglycemia. - Use caution in patients with diabetes mellitus or impaired glucose tolerance. - Adjust infusion rate in individuals with renal or hepatic dysfunction. - Monitor fluid balance and electrolytes, especially sodium and potassium. - Avoid rapid administration in neonates and infants. - Consider compatibility with other intravenous drugs to prevent precipitation.

Glukoza Braun may interact with other medications administered intravenously or affect the pharmacodynamics of certain drugs.

Avoid: - Concurrent use of high‑dose insulin without appropriate glucose monitoring. - Co‑administration with other hypertonic carbohydrate solutions that could exacerbate hyperglycemia.

Use with caution: - Loop diuretics, which may increase the risk of electrolyte disturbances. - Catecholamines (e.g., epinephrine) that raise blood glucose levels. - Sodium‑containing IV fluids, which may contribute to fluid overload. - Certain antibiotics (e.g., aminoglycosides) that require careful renal monitoring when large fluid volumes are given.